(Q40598502)

21 September 2017

Determinants and prognoses of locoregional and distant progression in breast cancer (English)

1 reference

21 September 2017

Jutta Engel

1

1 reference

21 September 2017

Renate Eckel

2

1 reference

21 September 2017

Ulker Aydemir

3

1 reference

21 September 2017

Sibel Aydemir

4

1 reference

21 September 2017

Jacqueline Kerr

5

1 reference

21 September 2017

Anne Schlesinger-Raab

6

1 reference

21 September 2017

P Dirschedl

7

1 reference

21 September 2017

D Hölzel

8

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

International Journal of Radiation Oncology Biology Physics

21 September 2017

1 reference

21 September 2017

55

1 reference

21 September 2017

1186-1195

1 reference

21 September 2017

5

1 reference

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Time trends in systemic adjuvant treatment for node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

A linear regression model for the analysis of life times

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Analysis of time-dependent covariates in failure time data

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Dormancy of mammary carcinoma after mastectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Local and distant recurrence after conservative management of "very low-risk" breast cancer are dependent events: a 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Annual hazard rates of recurrence for breast cancer after primary therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

The metastasis-free interval following curative treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Human breast cancer: survival from first metastasis. Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Proposal for a new model of breast cancer metastatic development

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Conditional median survival of patients with advanced carcinoma: surveillance, epidemiology, and end results data

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Screening for recurrent breast cancer--its effectiveness and prognostic value.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Incidence and time of occurrence of regional recurrence in stage I-II breast cancer: value of adjuvant irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

[A model for primary and secondary metastasis in breast cancer and the clinical consequences]

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

The link between local recurrence and distant metastases in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904476-0

7 January 2021

10.1016/S0360-3016(02)04476-0

Identifiers

DOI

1 reference

21 September 2017

1 reference